Correlation Between 10X Genomics and R1 RCM

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both 10X Genomics and R1 RCM at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 10X Genomics and R1 RCM into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 10X Genomics and R1 RCM Inc, you can compare the effects of market volatilities on 10X Genomics and R1 RCM and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 10X Genomics with a short position of R1 RCM. Check out your portfolio center. Please also check ongoing floating volatility patterns of 10X Genomics and R1 RCM.

Diversification Opportunities for 10X Genomics and R1 RCM

-0.84
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between 10X and RCM is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding 10X Genomics and R1 RCM Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on R1 RCM Inc and 10X Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 10X Genomics are associated (or correlated) with R1 RCM. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of R1 RCM Inc has no effect on the direction of 10X Genomics i.e., 10X Genomics and R1 RCM go up and down completely randomly.

Pair Corralation between 10X Genomics and R1 RCM

Considering the 90-day investment horizon 10X Genomics is expected to generate 111.27 times more return on investment than R1 RCM. However, 10X Genomics is 111.27 times more volatile than R1 RCM Inc. It trades about 0.03 of its potential returns per unit of risk. R1 RCM Inc is currently generating about 0.5 per unit of risk. If you would invest  1,412  in 10X Genomics on September 15, 2024 and sell it today you would earn a total of  9.00  from holding 10X Genomics or generate 0.64% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy18.18%
ValuesDaily Returns

10X Genomics  vs.  R1 RCM Inc

 Performance 
       Timeline  
10X Genomics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days 10X Genomics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
R1 RCM Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Good
Over the last 90 days R1 RCM Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental indicators, R1 RCM is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

10X Genomics and R1 RCM Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with 10X Genomics and R1 RCM

The main advantage of trading using opposite 10X Genomics and R1 RCM positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 10X Genomics position performs unexpectedly, R1 RCM can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in R1 RCM will offset losses from the drop in R1 RCM's long position.
The idea behind 10X Genomics and R1 RCM Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Fundamental Analysis
View fundamental data based on most recent published financial statements
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges